Augmentation strategies for intravenous ketamine in treatment-resistant depression: A systematic review and meta-analysis.
Overall, low-certainty randomized evidence is insufficient to support routine augmentation of IV ketamine for TRD, highlighting the need for larger, rigorously designed trials to determine whether specific strategies can meaningfully extend ketamine's antidepressant effects.